ARMISTICE CAPITAL LLC 13D and 13G filings for Kairos Pharma, Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 9:12 pm Sale | 2025-06-30 | 13G | Kairos Pharma, Ltd. KAPA | ARMISTICE CAPITAL LLC | 884,938 4.990% | -811,986 (-47.85%) | Filing |
| 2025-05-15 3:19 pm Purchase | 2025-03-31 | 13G | Kairos Pharma, Ltd. KAPA | ARMISTICE CAPITAL LLC | 1,696,924 9.990% | 1,696,924 (New Position) | Filing |